Clinical Trial Update: Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) [Phase 3]

View source ↗

Summary

Phase 3 adjuvant chemotherapy trial ACTS-GC evaluating TS-1 for gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED